The biotechnology company will use the federal pilot program for its planned $2 billion Saratoga Springs manufacturing campus ...
Immuron Engages Pullan Consulting to Advance IMM-529 Partnering Strategy; Immuron is seeking a partner to support clinical development through regulatory approval and ...
The U.S. Food and Drug Administration (FDA) has officially dropped its warning letter and enforcement complaint against Whoop ...
Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...
He told the Chronicle that his experience with the substance took him on a “journey through outer space.” During his mental ...
Just in time for the beginning of summer, the Food and Drug Administration has approved a new sunscreen ingredient for the ...
Orca Bio has jumped into the commercial market with FDA approval for Tregzi, a first-of-its-kind engineered cell therapy for blood cancer patients requiring transplants. | Orca Bio has jumped into ...
As radiopharmaceutical therapy (RPT) expands beyond neuroendocrine tumors and prostate cancer, it is important to understand ...
The FDA said the decision was based on scientific evidence that the Zyns expose users to much fewer harmful chemicals than cigarettes.
Anthropic may look like today’s loser. We should worry that this episode could make it tomorrow’s government-picked winner.
An FDA staff recommendation undercut the health secretary’s push on the chains of amino acids that are increasingly marketed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results